6-KThe Wire
TAKEDA PHARMACEUTICAL CO LTD files 6-K
Filed Jun 24, 2026 · 9d ago · Accession 0001395064-26-000183
Plain English
Takeda Pharmaceutical Company Limited announced changes to its Board of Directors, including the appointment of Julie Kim as Representative Director, President, and CEO.
Filing details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Ticker
- TAK
- CIK
- 1395064
- Form type
- 6-K
- Filing date
- Jun 24, 2026
- Report date
- Jun 24, 2026
- Document
- form6k-2_062426.htm
- Size
- 1.3 MB